Ascorbic acid and the brain: Rationale for the use against cognitive decline

Nutrients

Volumn 6, Issue 4, 2014, Pages 1752-1781

  Harrison, Fiona E ^a   Bowman, Gene L ^b   Polidori, Maria Cristina ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Aging; Alzheimer's disease; Ascorbic acid; Blood brain barrier; Brain; Cognitive function; Dementia; Elderly; Endothelial function; SVCT (sodium dependent vitamin C transporter); Vitamin C

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; DOPAMINE; GLUTATHIONE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; SODIUM ASCORBIC ACID COTRANSPORTER;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN; CEREBROSPINAL FLUID; COGNITION; COMORBIDITY; DEMENTIA; DIET SUPPLEMENTATION; DIETARY INTAKE; HUMAN; LIPID PEROXIDATION; MORTALITY; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; AGING; ANIMAL; BLOOD; COGNITION DISORDERS; DISEASE MODEL; DRUG EFFECTS; METABOLISM; OBSERVATIONAL STUDY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGING; ALZHEIMER DISEASE; ANIMALS; ASCORBIC ACID; BRAIN; COGNITION; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 84899640018     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6041752     Document Type: Review

References (160)

1. Nishikimi, M.; Fukuyama, R.; Minoshima, S.; Yagi, K. Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-gamma-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man. J. Biol. Chem. 1994, 269, 13685-13688.
2. Frei, B.; England, L.; Ames, B. N. Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA 1989, 86, 6377-6381.
3. Berger, T. M.; Polidori, M. C.; Dabbagh, A.; Evans, P. J.; Halliwell, B.; Morrow, J. D.; Roberts, L. J., II; Frei, B. Antioxidant activity of vitamin C in iron-overloaded human plasma. J. Biol. Chem. 1997, 272, 15656-15660.
4. Traber, M. G.; Stevens, J. F. Vitamins C and E: Beneficial effects from a mechanistic perspective. Free Radic. Biol. Med. 1997, 51, 1000-1013.
5. Prince, M.; Bryce, R.; Albanese, E.; Wimo, A.; Ribeiro, W.; Ferri, C. P. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimer's Dement. 2013, 9, 63-75 e62.
6. Pratico, D.; Clark, C. M.; Liun, F.; Rokach, J.; Lee, V. Y.; Trojanowski, J. Q. Increase of brain oxidative stress in mild cognitive impairment: A possible predictor of Alzheimer disease. Arch. Neurol. 2002, 59, 972-976.
7. Rinaldi, P.; Polidori, M. C.; Metastasio, A.; Mariani, E.; Mattioli, P.; Cherubini, A.; Catani, M.; Cecchetti, R.; Senin, U.; Mecocci, P. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol. Aging 2003, 24, 915-919.
8. Mecocci, P.; Polidori, M. C. Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease. Biochim. Biophys. Acta 2012, 1822, 631-638.
9. Mangialasche, F.; Kivipelto, M.; Mecocci, P.; Rizzuto, D.; Palmer, K.; Winblad, B.; Fratiglioni, L. High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age. J. Alzheimer's Dis. (JAD) 2010, 20, 1029-1037.
10. Raynaud-Simon, A.; Cohen-Bittan, J.; Gouronnec, A.; Pautas, E.; Senet, P.; Verny, M.; Boddaert, J. Scurvy in hospitalized elderly patients. J. Nutr. Health Aging 2010, 14, 407-410.
11. Harrison, F. E.; Green, R. J.; Dawes, S. M.; May, J. M. Vitamin C distribution and retention in the mouse brain. Brain Res. 2010, 1348, 181-186.
12. Brubacher, D.; Moser, U.; Jordan, P. Vitamin C concentrations in plasma as a function of intake: A meta-analysis. Int. J. Vitam Nutr. Res. 2000, 70, 226-237.
13. Harrison, F. E.; May, J. M. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol. Med. 2009, 46, 719-730.
14. Kaliora, A. C.; Dedoussis, G. V.; Schmidt, H. Dietary antioxidants in preventing atherogenesis. Atherosclerosis 2006, 187, 1-17.
15. May, J. M.; Harrison, F. E. Role of Vitamin C in the Function of the Vascular Endothelium. Antioxid. Redox Signal. 2013, 19, 2068-2083.
16. Proper, E. A.; Hoogland, G.; Kappen, S. M.; Jansen, G. H.; Rensen, M. G.; Schrama, L. H.; van Veelen, C. W.; van Rijen, P. C.; van Nieuwenhuizen, O.; Gispen, W. H.; et al. Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 2002, 125, 32-43.
17. Wilson, J. X.; Peters, C. E.; Sitar, S. M.; Daoust, P.; Gelb, A. W. Glutamate stimulates ascorbate transport by astrocytes. Brain Res. 2000, 858, 61-66.
18. Estrada-Sanchez, A. M.; Rebec, G. V. Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: Interactions between neurons and astrocytes. Basal Ganglia 2012, 2, 57-66.
19. Ballaz, S.; Morales, I.; Rodriguez, M.; Obeso, J. A. Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons. J. Neurosci. Res. 2013, 91, 1609-1617.
20. Dorner, J. L.; Miller, B. R.; Klein, E. L.; Murphy-Nakhnikian, A.; Andrews, R. L.; Barton, S. J.; Rebec, G. V. Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of Huntington's disease. Brain Res. 2009, 1290, 111-120.
21. Rebec, G. V.; Pierce, R. C. A vitamin as neuromodulator: Ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog. Neurobiol. 1994, 43, 537-565.
22. Rebec, G. V.; Barton, S. J.; Marseilles, A. M.; Collins, K. Ascorbate treatment attenuates the Huntington behavioral phenotype in mice. Neuroreport 2003, 14, 1263-1265.
23. Spector, R.; Johanson, C. E. The nexus of vitamin homeostasis and DNA synthesis and modification in mammalian brain. Mol. Brain 2014, 7, 3.
24. Blaschke, K.; Ebata, K. T.; Karimi, M. M.; Zepeda-Martinez, J. A.; Goyal, P.; Mahapatra, S.; Tam, A.; Laird, D. J.; Hirst, M.; Rao, A.; et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 2013, 500, 222-226.
25. Yin, R.; Mao, S. Q.; Zhao, B.; Chong, Z.; Yang, Y.; Zhao, C.; Zhang, D.; Huang, H.; Gao, J.; Li, Z.; et al. Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J. Am. Chem. Soc. 2013, 135, 10396-10403.
26. Minor, E. A.; Court, B. L.; Young, J. I.; Wang, G. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J. Biol. Chem. 2013, 288, 13669-13674.
27. Rudenko, A.; Dawlaty, M. M.; Seo, J.; Cheng, A. W.; Meng, J.; Le, T.; Faull, K. F.; Jaenisch, R.; Tsai, L. H. Tet1 is critical for neuronal activity-regulated gene expression and memory extinction. Neuron 2013, 79, 1109-1122.
28. Meister, A. Glutathione, ascorbate, and cellular protection. Cancer Res. 1994, 54, 1969s-1975s.
29. Smuda, D. G. M. Maillard degradation pathways of vitamin C. Angew. Chem. Int. Ed. 2013, 52, 4887-4891.
30. Fan, X.; Reneker, L. W.; Obrenovich, M. E.; Strauch, C.; Cheng, R.; Jarvis, S. M.; Ortwerth, B. J.; Monnier, V. M. Vitamin C mediates chemical aging of lens crystallins by the Maillard reaction in a humanized mouse model. Proc. Natl. Acad. Sci. USA 2006, 103, 16912-16917.
31. Carr, A.; Frei, B. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J. 1999, 13, 1007-1024.
32. Halliwell, B. Vitamin C: Antioxidant or pro-oxidant in vivo? Free Radic. Res. 1996, 25, 439-454.
33. Premkumar, K.; Bowlus, C. L. Ascorbic acid does not increase the oxidative stress induced by dietary iron in C3H mice. J. Nutr. 2004, 134, 435-438.
34. Collis, C. S.; Yang, M.; Diplock, A. T.; Hallinan T.; Rice-Evans, C. A. Effects of co-supplementation of iron with ascorbic acid on antioxidant-Pro-oxidant balance in the guinea pig. Free Radic. Res. 1997, 27, 113-121.
35. Gerster, H. High-dose vitamin C: A risk for persons with high iron stores? Int. J. Vitam Nutr. Res. 1999, 69, 67-82.
36. Loef, M.; Walach, H. Copper and iron in Alzheimer's disease: A systematic review and its dietary implications. Br. J. Nutr. 2012, 107, 7-19.
37. Crespo, A. C.; Silva, B.; Marques, L.; Marcelino, E.; Maruta, C.; Costa, S.; Timoteo, A.; Vilares, A.; Couto, F. S.; Faustino, P.; et al. Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation. Neurobiol. Aging 2014, 35, 777-785.
38. Sinha, M.; Bhowmick, P.; Banerjee, A.; Chakrabarti, S. Antioxidant role of amyloid beta protein in cell-free and biological systems: Implication for the pathogenesis of Alzheimer disease. Free Radic. Biol. Med. 2013, 56, 184-192.
39. Hammarstrom, L. Autoradiographic studies on the distribution of C14-labelled ascorbic acid and dehydroascorbic acid. Acta Physiol. Scand. 1966, 70, 3-83.
40. Spector, R.; Lorenzo, A. V. Ascorbic acid homeostasis in the central nervous system. Am. J. Physiol. 1973, 225, 757-763.
41. Savini, I.; Rossi, A.; Pierro, C.; Avigliano, L.; Catani, M. V. SVCT1 and SVCT2: Key proteins for vitamin C uptake. Amino Acids 2008, 34, 347-355.
42. Tsukaguchi, H.; Tokui, T.; Mackenzie, B.; Berger, U. V.; Chen, X. Z.; Wang, Y.; Brubaker, R. F.; Hediger, M. A. A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature 1999, 399, 70-75.
43. Wang, Y.; Mackenzie, B.; Tsukaguchi, H.; Weremowicz, S.; Morton, C. C.; Hediger, M. A. Human vitamin C (L-ascorbic acid) transporter SVCT1. Biochem. Biophys. Res. Commun. 2000, 267, 488-494.
44. Lindblad, M.; Tveden-Nyborg, P.; Lykkesfeldt, J. Regulation of Vitamin C Homeostasis during Deficiency. Nutrients 2013, 5, 2860-2879.
45. Erichsen, H. C.; Eck, P.; Levine, M.; Chanock, S. Characterization of the genomic structure of the human vitamin C transporter SVCT1 (SLC23A2). J. Nutr. 2001, 131, 2623-2627.
46. Erichsen, H. C.; Peters, U.; Eck, P.; Welch, R.; Schoen, R. E.; Yeager, M.; Levine, M.; Hayes, R. B.; Chanock, S. Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma. Nutr. Cancer 2008, 60, 652-659.
47. Michels, A. J.; Hagen, T. M.; Frei, B. Human genetic variation influences vitamin C homeostasis by altering vitamin C transport and antioxidant enzyme function. Annu. Rev. Nutr. 2013, 33, 45-70.
48. Eck, P.; Erichsen, H. C.; Taylor, J. G.; Corpe, C.; Chanock, S. J.; Levine, M. Genomic and functional analysis of the sodium-dependent vitamin C transporter SLC23A1-SVCT1. Genes Nutr. 2007, 2, 143-145.
49. Corpe, C. P.; Tu, H.; Eck, P.; Wang, J.; Faulhaber-Walter, R.; Schnermann, J.; Margolis, S.; Padayatty, S.; Sun, H.; Wang, Y.; et al. Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice. J. Clin. Invest. 2010, 120, 1069-1083.
50. Hierro, C.; Monte, M. J.; Lozano, E.; Gonzalez-Sanchez, E.; Marin, J. J.; Macias, R. I. Liver metabolic/oxidative stress induces hepatic and extrahepatic changes in the expression of the vitamin C transporters SVCT1 and SVCT2. Eur. J. Nutr. 2014, 53, 401-412.
51. Gess, B.; Sevimli, S.; Strecker, J. K.; Young, P.; Schabitz, W. R. Sodium-dependent vitamin C transporter 2 (SVCT2) expression and activity in brain capillary endothelial cells after transient ischemia in mice. PLoS One 2011, 6, e17139.
52. May, J. M.; Qu, Z. C. Ascorbic acid prevents increased endothelial permeability caused by oxidized low density lipoprotein. Free Radic. Res. 2010, 44, 1359-1368.
53. May, J. M.; Qu, Z. C. Ascorbic acid prevents oxidant-induced increases in endothelial permeability. Biofactors 2011, 37, 46-50.
54. Amano, A.; Aigaki, T.; Maruyama, N.; Ishigami, A. Ascorbic acid depletion enhances expression of the sodium-dependent vitamin C transporters, SVCT1 and SVCT2, and uptake of ascorbic acid in livers of SMP30/GNL knockout mice. Arch. Biochem. Biophys. 2010, 496, 38-44.
55. Meredith, M. E.; Harrison, F. E.; May, J. M. Differential regulation of the ascorbic acid transporter SVCT2 during development and in response to ascorbic acid depletion. Biochem. Biophys. Res. Commun. 2011, 414, 737-742.
56. Nualart, F.; Castro, T.; Low, M.; Henriquez, J. P.; Oyarce, K.; Cisternas, P.; Garcia, A.; Yanez, A. J.; Bertinat, R.; Montecinos, V. P.; et al. Dynamic expression of the sodium-vitamin C co-transporters, SVCT1 and SVCT2, during perinatal kidney development. Histochem. Cell Biol. 2013, 139, 233-247.
57. Jimenez-Fernandez, E.; Ponce, M.; Zuasti, E.; Fernandez-Diaz, C.; Manchado, M.; Infante, C. Molecular characterization and transcriptional regulation of the sodium-dependent vitamin C transporter genes (slc23a1 and slc23a2) in a teleost fish, the Senegalese sole (Solea senegalensis). Comp. Biochem. Physiol. Part B Biochem. Mol. Biol. 2012, 161, 208-218.
58. Gess, B.; Lohmann, C.; Halfter, H.; Young, P. Sodium-dependent vitamin C transporter 2 (SVCT2) is necessary for the uptake of L-ascorbic acid into Schwann cells. Glia 2010, 58, 287-299.
59. Maulen, N. P.; Henriquez, E. A.; Kempe, S.; Carcamo, J. G.; Schmid-Kotsas, A.; Bachem, M.; Grunert, A.; Bustamante, M. E.; Nualart, F.; Vera, J. C. Up-regulation and polarized expression of the sodium-ascorbic acid transporter SVCT1 in post-confluent differentiated CaCo-2 cells. J. Biol. Chem. 2003, 278, 9035-9041.
60. Boyer, J. C.; Campbell, C. E.; Sigurdson, W. J.; Kuo, S. M. Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells. Biochem. Biophys. Res. Commun. 2005, 334, 150-156.
61. MacDonald, L.; Thumser, A. E.; Sharp, P. Decreased expression of the vitamin C transporter SVCT1 by ascorbic acid in a human intestinal epithelial cell line. Br. J. Nutr. 2002, 87, 97-100.
62. Varma, S.; Sobey, K.; Campbell, C. E.; Kuo, S. M. Hierarchal contribution of N-and C-terminal sequences to the differential localization of homologous sodium-dependent vitamin C transporters, SVCT1 and SVCT2, in epithelial cells. Biochemistry 2009, 48, 2969-2980.
63. May, J. M.; Li, L.; Qu, Z. C. Oxidized LDL up-regulates the ascorbic acid transporter SVCT2 in endothelial cells. Mol. Cell. Biochem. 2010, 343, 217-222.
64. Qiao, H.; May, J. M. Development of ascorbate transporters in brain cortical capillary endothelial cells in culture. Brain Res. 2008, 1208, 79-86.
65. Chothe, P. P.; Chutkan, N.; Sangani, R.; Wenger, K. H.; Prasad, P. D.; Thangaraju, M.; Hamrick, M. W.; Isales, C. M.; Ganapathy, V.; Fulzele, S. Sodium-coupled vitamin C transporter (SVCT2): expression, function, and regulation in intervertebral disc cells. Spine J. 2013, 13, 549-557.
66. Berger, U. V.; Hediger, M. A. The vitamin C transporter SVCT2 is expressed by astrocytes in culture but not in situ. Neuroreport 2000, 11, 1395-1399.
67. Korcok, J.; Yan, R.; Siushansian, R.; Dixon, S. J.; Wilson, J. X. Sodium-ascorbate cotransport controls intracellular ascorbate concentration in primary astrocyte cultures expressing the SVCT2 transporter. Brain Res. 2000, 881, 144-151.
68. Oke, A. F.; May, L.; Adams, R. N. Ascorbic acid distribution patterns in human brain. A comparison with nonhuman mammalian species. Ann. N. Y. Acad. Sci. 1987, 498, 1-12.
69. Mefford, I. N.; Oke, A. F.; Adams, R. N. Regional distribution of ascorbate in human brain. Brain Res. 1981, 212, 223-226.
70. Rice, M. E.; Russo-Menna, I. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience 1998, 82, 1213-1223.
71. Caprile, T.; Salazar, K.; Astuya, A.; Cisternas, P.; Silva-Alvarez, C.; Montecinos, H.; Millan, C.; de Los Angeles Garcia, M.; Nualart, F. The Na+-dependent L-ascorbic acid transporter SVCT2 expressed in brainstem cells, neurons, and neuroblastoma cells is inhibited by flavonoids. J. Neurochem. 2009, 108, 563-577.
72. Qiu, S.; Li, L.; Weeber, E. J.; May, J. M. Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity. J. Neurosci. Res. 2007, 85, 1046-1056.
73. Mun, G. H.; Kim, M. J.; Lee, J. H.; Kim, H. J.; Chung, Y. H.; Chung, Y. B.; Kang, J. S.; Hwang, Y. I.; Oh, S. H.; Kim, J. G.; et al. Immunohistochemical study of the distribution of sodium-dependent vitamin C transporters in adult rat brain. J. Neurosci. Res. 2006, 83, 919-928.
74. Garcia Mde, L.; Salazar, K.; Millan, C.; Rodriguez, F.; Montecinos, H.; Caprile, T.; Silva, C.; Cortes, C.; Reinicke, K.; Vera, J. C.; et al. Sodium vitamin C cotransporter SVCT2 is expressed in hypothalamic glial cells. Glia 2005, 50, 32-47.
75. Chinoy, N. J.; Sanjeevan, A. G. On the specificity of alcoholic acidic silver nitrate reagent for the histochemical localization of ascorbic acid. A reappraisal. Histochemistry 1978, 56, 275-282.
76. Berger, U. V.; Lu, X. C.; Liu, W.; Tang, Z.; Slusher, B. S.; Hediger, M. A. Effect of middle cerebral artery occlusion on mRNA expression for the sodium-coupled vitamin C transporter SVCT2 in rat brain. J. Neurochem. 2003, 86, 896-906.
77. McHenry, E. W.; Reedman, E. J.; Sheppard, M. The physiological properties of ascorbic acid: An effect upon the weights of guinea-pigs. Biochem. J. 1938, 32, 1302-1304.
78. Svirbely, J. L.; Szent-Gyorgyi, A. The chemical nature of vitamin C. Biochem. J. 1932, 26, 865-870.
79. Szent-Gyorgyi, A. H. W. N. "Hexuronic Acid" (Ascorbic Acid) as the Antiscorbutic Factor. Nature 1933, 131, 24.
80. Anderson WES, A. H. The effect of acute scurvy on the subsequent nutrition and growth of guinea pigs. J. Biol. Chem. 1924, 61, 181-191.
81. Burk, R. F.; Christensen, J. M.; Maguire, M. J.; Austin, L. M.; Whetsell, W. O., Jr.; May, J. M.; Hill, K. E.; Ebner, F. F. A combined deficiency of vitamins E and C causes severe central nervous system damage in guinea pigs. J. Nutr. 2006, 136, 1576-1581.
82. Hill, K. E.; Motley, A. K.; May, J. M.; Burk, R. F. Combined selenium and vitamin C deficiency causes cell death in guinea pig skeletal muscle. Nutr. Res. 2009, 29, 213-219.
83. Frikke-Schmidt, H.; Lykkesfeldt, J. Role of marginal vitamin C deficiency in atherogenesis: In vivo models and clinical studies. Basic Clin. Pharmacol. Toxicol. 2009, 104, 419-433.
84. Maeda, N.; Hagihara, H.; Nakata, Y.; Hiller, S.; Wilder, J.; Reddick, R. Aortic wall damage in mice unable to synthesize ascorbic acid. Proc. Natl. Acad. Sci. USA 2000, 97, 841-846.
85. Harrison, F. E.; Meredith, M. E.; Dawes, S. M.; Saskowski, J. L.; May, J. M. Low ascorbic acid and increased oxidative stress in gulo(-/-) mice during development. Brain Res. 2010, 1349, 143-152.
86. Harrison, F. E.; Yu, S. S.; Van Den Bossche, K. L.; Li, L.; May, J. M.; McDonald, M. P. Elevated oxidative stress and sensorimotor deficits but normal cognition in mice that cannot synthesize ascorbic acid. J. Neurochem. 2008, 106, 1198-1208.
87. Chen, Y.; Curran, C. P.; Nebert, D. W.; Patel, K. V.; Williams, M. T.; Vorhees, C. V. Effect of vitamin C deficiency during postnatal development on adult behavior: functional phenotype of Gulo(-/-) knockout mice. Genes Brain Behav. 2012, 11, 269-277.
88. Harrison, F. E.; May, J. M.; McDonald, M. P. Vitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic mice. Pharmacol. Biochem. Behav. 2010, 94, 543-552.
89. Duggan, G. E.; Joan Miller, B.; Jirik, F. R.; Vogel, H. J. Metabolic profiling of vitamin C deficiency in Gulo-/-mice using proton NMR spectroscopy. J. Biomol. NMR 2011, 49, 165-173.
90. Vissers, M. C.; Wilkie, R. P. Ascorbate deficiency results in impaired neutrophil apoptosis and clearance and is associated with up-regulation of hypoxia-inducible factor 1alpha. J. Leukoc. Biol. 2007, 81, 1236-1244.
91. Ishigami, A.; Fujita, T.; Handa, S.; Shirasawa, T.; Koseki, H.; Kitamura, T.; Enomoto, N.; Sato, N.; Shimosawa, T.; Maruyama, N. Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha-and Fas-mediated apoptosis. Am. J. Pathol. 2002, 161, 1273-1281.
92. Kondo, Y.; Inai, Y.; Sato, Y.; Handa, S.; Kubo, S.; Shimokado, K.; Goto, S.; Nishikimi, M.; Maruyama, N.; Ishigami, A. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc. Natl. Acad. Sci. USA 2006, 103, 5723-5728.
93. Kondo, Y.; Sasaki, T.; Sato, Y.; Amano, A.; Aizawa, S.; Iwama, M.; Handa, S.; Shimada, N.; Fukuda, M.; Akita, M.; et al. Vitamin C depletion increases superoxide generation in brains of SMP30/GNL knockout mice. Biochem. Biophys. Res. Commun. 2008, 377, 291-296.
94. Son, T. G.; Zou, Y.; Jung, K. J.; Yu, B. P.; Ishigami, A.; Maruyama, N.; Lee, J. SMP30 deficiency causes increased oxidative stress in brain. Mech. Ageing Dev. 2006, 127, 451-457.
95. Beamer, W. G.; Rosen, C. J.; Bronson, R. T.; Gu, W.; Donahue, L. R.; Baylink, D. J.; Richardson, C. C.; Crawford, G. C.; Barker, J. E. Spontaneous fracture (sfx): A mouse genetic model of defective peripubertal bone formation. Bone 2000, 27, 619-626.
96. Mohan, S.; Kapoor, A.; Singgih, A.; Zhang, Z.; Taylor, T.; Yu, H.; Chadwick, R. B.; Chung, Y. S.; Donahue, L. R.; Rosen, C.; et al. Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency. J. Bone Miner. Res. 2005, 20, 1597-1610.
97. Jiao, Y.; Zhang, J.; Yan, J.; Stuart, J.; Gibson, G.; Lu, L.; Willaims, R.; Wang, Y. J.; Gu, W. Differential gene expression between wild-type and Gulo-deficient mice supplied with vitamin C. Genet. Mol. Biol. 2011, 34, 386-395.
98. Ward, M. S.; Lamb, J.; May, J. M.; Harrison, F. E. Behavioral and monoamine changes following severe vitamin C deficiency. J. Neurochem. 2013, 124, 363-375.
99. Amano, A.; Tsunoda, M.; Aigaki, T.; Maruyama, N.; Ishigami, A. Effect of ascorbic acid deficiency on catecholamine synthesis in adrenal glands of SMP30/GNL knockout mice. Eur. J. Nutr. 2014, 53, 177-185.
100. Sotiriou, S.; Gispert, S.; Cheng, J.; Wang, Y.; Chen, A.; Hoogstraten-Miller, S.; Miller, G. F.; Kwon, O.; Levine, M.; Guttentag, S. H.; et al. Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat. Med. 2002, 8, 514-517.
101. Harrison, F. E.; Dawes, S. M.; Meredith, M. E.; Babaev, V. R.; Li, L.; May, J. M. Low vitamin C and increased oxidative stress and cell death in mice that lack the sodium-dependent vitamin C transporter SVCT2. Free Radic. Biol. Med. 2010, 49, 821-829.
102. Bornstein, S. R.; Yoshida-Hiroi, M.; Sotiriou, S.; Levine, M.; Hartwig, H. G.; Nussbaum, R. L.; Eisenhofer, G. Impaired adrenal catecholamine system function in mice with deficiency of the ascorbic acid transporter (SVCT2). FASEB J. 2003, 17, 1928-1930.
103. Meredith, M. E.; May, J. M. Regulation of embryonic neurotransmitter and tyrosine hydroxylase protein levels by ascorbic acid. Brain Res. 2013, 1539, 7-14.
104. Harrison, F. E.; Best, J. L.; Meredith, M. E.; Gamlin, C. R.; Borza, D. B.; May, J. M. Increased expression of SVCT2 in a new mouse model raises ascorbic acid in tissues and protects against paraquat-induced oxidative damage in lung. PLoS One 2012, 7, e35623.
105. Babaev, V. R.; Whitesell, R. R.; Li, L.; Linton, M. F.; Fazio, S.; May, J. M. Selective macrophage ascorbate deficiency suppresses early atherosclerosis. Free Radic. Biol. Med. 2011, 50, 27-36.
106. Babaev, V. R.; Li, L.; Shah, S.; Fazio, S.; Linton, M. F.; May, J. M. Combined vitamin C and vitamin E deficiency worsens early atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 1751-1757.
107. Kook, S. Y.; Lee, K. M.; Kim, Y.; Cha, M. Y.; Kang, S.; Baik, S. H.; Lee, H.; Park, R.; Mook-Jung, I. High-dose of vitamin C supplementation reduces amyloid plaque burden and ameliorates pathological changes in the brain of 5XFAD mice. Cell. Death Dis. 2014, 5, e1083.
108. Pierce, M. R.; Diasio, D. L.; Rodrigues, L. M.; Harrison, F. E.; May, J. M. Combined vitamin C and E deficiency induces motor defects in gulo(-/-)/SVCT2(+/-) mice. Nutr. Neurosci. 2013, 16, 160-173.
109. Morris, M. C.; Beckett, L. A.; Scherr, P. A.; Hebert, L. E.; Bennett, D. A.; Field, T. S.; Evans, D. A. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis. Assoc. Disord. 1998, 12, 121-126.
110. Morris, M. C.; Evans, D. A.; Bienias, J. L.; Tangney, C. C.; Bennett, D. A.; Aggarwal, N.; Wilson, R. S.; Scherr, P. A. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002, 287, 3230-3237.
111. Carr, A. C.; Bozonet, S. M.; Pullar, J. M.; Simcock, J. W.; Vissers, M. C. A Randomized Steady-State Bioavailability Study of Synthetic versus Natural (Kiwifruit-Derived) Vitamin C. Nutrients 2013, 5, 3684-3695.
112. Gray, S. L.; Anderson, M. L.; Crane, P. K.; Breitner, J. C.; McCormick, W.; Bowen, J. D.; Teri, L.; Larson, E. Antioxidant vitamin supplement use and risk of dementia or Alzheimer's disease in older adults. J. Am. Geriatr. Soc. 2008, 56, 291-295.
113. Luchsinger, J. A.; Tang, M. X.; Shea, S.; Mayeux, R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch. Neurol. 2003, 60, 203-208.
114. Masaki, K. H.; Losonczy, K. G.; Izmirlian, G.; Foley, D. J.; Ross, G. W.; Petrovitch, H.; Havlik, R.; White, L. R. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000, 54, 1265-1272.
115. Zandi, P. P.; Anthony, J. C.; Khachaturian, A. S.; Stone, S. V.; Gustafson, D.; Tschanz, J. T.; Norton, M. C.; Welsh-Bohmer, K. A.; Breitner, J. C. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch. Neurol. 2004, 61, 82-88.
116. Grodstein, F.; Chen, J.; Willett, W. C. High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am. J. Clin. Nutr. 2003, 77, 975-984.
117. Devore, E. E.; Kang, J. H.; Stampfer, M. J.; Grodstein, F. The association of antioxidants and cognition in the Nurses' Health Study. Am. J. Epidemiol. 2013, 177, 33-41.
118. Engelhart, M. J.; Geerlings, M. I.; Ruitenberg, A.; van Swieten, J. C.; Hofman, A.; Witteman, J. C.; Breteler, M. M. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002, 287, 3223-3229.
119. Bowman, G. L.; Shannon, J.; Ho, E.; Traber, M. G.; Frei, B.; Oken, B. S.; Kaye, J. A.; Quinn, J. F. Reliability and validity of food frequency questionnaire and nutrient biomarkers in elders with and without mild cognitive impairment. Alzheimer Dis. Assoc. Disord. 2011, 25, 49-57.
120. Rodrigue, K. M.; Kennedy, K. M.; Devous, M. D., Sr.; Rieck, J. R.; Hebrank, A. C.; Diaz-Arrastia, R.; Mathews, D.; Park, D. C. beta-Amyloid burden in healthy aging: Regional distribution and cognitive consequences. Neurology 2012, 78, 387-395.
121. Bowman, G. L.; Silbert, L. C.; Howieson, D.; Dodge, H. H.; Traber, M. G.; Frei, B.; Kaye, J. A.; Shannon, J.; Quinn, J. F. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 2012, 78, 241-249.
122. Bowman, G. L. Ascorbic acid, cognitive function, and Alzheimer's disease: A current review and future direction. Biofactors 2012, 38, 114-122.
123. Goodwin, J. S.; Goodwin, J. M.; Garry, P. J. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983, 249, 2917-2921.
124. Gale, C. R.; Martyn, C. N.; Cooper, C. Cognitive impairment and mortality in a cohort of elderly people. BMJ 1996, 312, 608-611.
125. Riviere, S.; Birlouez-Aragon, I.; Nourhashemi, F.; Vellas, B. Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int. J. Geriatr. Psychiatry 1998, 13, 749-754.
126. Charlton, K. E.; Rabinowitz, T. L.; Geffen, L. N.; Dhansay, M. A. Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. J. Nutr. Health Aging 2004, 8, 99-107.
127. Polidori, M. C.; Mecocci, P. Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. J. Alzheimer's Dis. (JAD) 2002, 4, 517-522.
128. Polidori, M. C.; Mattioli, P.; Aldred, S.; Cecchetti, R.; Stahl, W.; Griffiths, H.; Senin, U.; Sies, H.; Mecocci, P. Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dement. Geriatr. Cogn. Disord. 2004, 18, 265-270.
129. Perrig, W. J.; Perrig, P.; Stahelin, H. B. The relation between antioxidants and memory performance in the old and very old. J. Am. Geriatr. Soc. 1997, 45, 718-724.
130. Spector, R. Nutrient transport systems in brain: 40 years of progress. J. Neurochem. 2009, 111, 315-320.
131. Paraskevas, G. P.; Kapaki, E.; Libitaki, G.; Zournas, C.; Segditsa, I.; Papageorgiou, C. Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease. Acta Neurol. Scand. 1997, 96, 88-90.
132. Quinn, J.; Suh, J.; Moore, M. M.; Kaye, J.; Frei, B. Antioxidants in Alzheimer's disease-vitamin C delivery to a demanding brain. J. Alzheimers Dis. 2003, 5, 309-313.
133. Glaso, M.; Nordbo, G.; Diep, L.; Bohmer, T. Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease. J. Nutr. Health Aging 2004, 8, 407-413.
134. Bowman, G. L.; Dodge, H.; Frei, B.; Calabrese, C.; Oken, B. S.; Kaye, J. A.; Quinn, J. F. Ascorbic acid and rates of cognitive decline in Alzheimer's disease. J. Alzheimers Dis. 2009, 16, 93-98.
135. Arlt, S.; Muller-Thomsen, T.; Beisiegel, U. K.; Ontush, A. Effect of One-Year Vitamin C-and E-Supplementation on Cerebrospinal Fluid Oxidation Parameters and Clinical Course in Alzheimer's Disease. Neurochem. Res. 2012, 37, 2706-2714.
136. Galasko, D. R.; Peskind, E.; Clark, C. M.; Quinn, J. F.; Ringman, J. M.; Jicha, G. A.; Cotman, C.; Cottrell, B.; Montine, T. J.; Thomas, R. G.; Aisen, P. Antioxidants for Alzheimer disease: A randomized clinical trial with cerebrospinal fluid biomarker measures. Arch. Neurol. 2012, 69, 836-841.
137. Spector, R.; Johanson, C. E. Sustained choroid plexus function in human elderly and Alzheimer's disease patients. Fluids Barriers CNS 2013, 10, 28.
138. Polidori, M. C.; Pientka, L. Bridging the pathophysiology of Alzheimer's disease with vascular pathology: the feed-back, the feed-forward, and oxidative stress. J. Alzheimer's Dis. (JAD) 2012, 28, 1-9.
139. Polidori, M. C.; Pientka, L.; Mecocci, P. A review of the major vascular risk factors related to Alzheimer's disease. J. Alzheimer's Dis. (JAD) 2012, 32, 521-530.
140. de la Torre, J. C. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. J. Alzheimer's Dis. (JAD) 2012, 32, 553-567.
141. Aguero-Torres, H.; Kivipelto, M.; von Strauss, E. Rethinking the dementia diagnoses in a population-based study: What is Alzheimer's disease and what is vascular dementia?. A study from the kungsholmen project. Dement. Geriatr. Cogn. Disord. 2006, 22, 244-249.
142. de la Torre, J. C.; Stefano, G. B. Evidence that Alzheimer's disease is a microvascular disorder: The role of constitutive nitric oxide. Brain Res. Brain Res. Rev. 2000, 34, 119-136.
143. Polidori, M. C.; Mecocci, P.; Frei, B. Plasma vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head trauma. Stroke 2001, 32, 898-902.
144. Knopman, D.; Boland, L. L.; Mosley, T.; Howard, G.; Liao, D.; Szklo, M.; McGovern, P.; Folsom, A. R. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001, 56, 42-48.
145. Polidori, M. C.; Pratico, D.; Savino, K.; Rokach, J.; Stahl, W.; Mecocci, P. Increased F2 isoprostane plasma levels in patients with congestive heart failure are correlated with antioxidant status and disease severity. J. Card. Fail. 2004, 10, 334-338.
146. Polidori, M. C.; Pratico, D.; Ingegni, T.; Mariani, E.; Spazzafumo, L.; Del Sindaco, P.; Cecchetti, R.; Yao, Y.; Ricci, S.; Cherubini, A.; et al. Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: Results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study. Biofactors 2005, 24, 265-274.
147. Wendell, C. R.; Zonderman, A. B.; Metter, E. J.; Najjar, S. S.; Waldstein, S. R. Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease. Stroke 2009, 40, 3180-3185.
148. Frei, B. To C or not to C, that is the question! J. Am. Coll. Cardiol. 2003, 42, 253-255.
149. Polidori, M. C.; Mecocci, P.; Reimann, A.; Cherubini, A.; Cecchetti, R.; Briviba, K.; Stahl, W.; Sies, H.; Senin, U. Plasma lipid peroxidation and vitamin C status in healthy centenarians. J. Am. Geriatr. Soc. 1999, 47, 1038-1039.
150. Hunter, D. C.; Skinner, M. A.; Wolber, F. M.; Booth, C. L.; Loh, J. M.; Wohlers, M.; Stevenson, L. M.; Kruger, M. C. Consumption of gold kiwifruit reduces severity and duration of selected upper respiratory tract infection symptoms and increases plasma vitamin C concentration in healthy older adults. Br. J. Nutr. 2012, 108, 1235-1245.
151. Moretti, M.; Colla, A.; de Oliveira Balen, G.; dos Santos, D. B.; Budni, J.; de Freitas, A. E.; Farina, M.; Severo Rodrigues, A. L. Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress. J. Psychiatr. Res. 2012, 46, 331-340.
152. Simon, J. A.; Hudes, E. S.; Tice, J. A. Relation of serum ascorbic acid to mortality among US adults. J. Am. Coll. Nutr. 2001, 20, 255-263.
153. Boekholdt, S. M.; Meuwese, M. C.; Day, N. E.; Luben, R.; Welch, A.; Wareham, N. J.; Khaw, K. T. Plasma concentrations of ascorbic acid and C-reactive protein, and risk of future coronary artery disease, in apparently healthy men and women: the EPIC-Norfolk prospective population study. Br. J. Nutr. 2006, 96, 516-522.
154. Khaw, K. T.; Bingham, S.; Welch, A.; Luben, R.; Wareham, N.; Oakes, S.; Day, N. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition. Lancet 2001, 357, 657-663.
155. Ellingsen, I.; Seljeflot, I.; Arnesen, H.; Tonstad, S. Vitamin C consumption is associated with less progression in carotid intima media thickness in elderly men: A 3-year intervention study. Nutr. Metab. Cardiovasc. Dis. (NMCD) 2009, 19, 8-14.
156. Hodis, H. N.; Mack, W. J.; LaBree, L.; Mahrer, P. R.; Sevanian, A.; Liu, C. R.; Liu, C. H.; Hwang, J.; Selzer, R. H.; Azen, S. P. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: The Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 2002, 106, 1453-1459.
157. Zureik, M.; Galan, P.; Bertrais, S.; Mennen, L.; Czernichow, S.; Blacher, J.; Ducimetiere, P.; Hercberg, S. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1485-1491.
158. Luzzi, S.; Vella, L.; Bartolini, M.; Provinciali, L.; Silvestrini, M. Atherosclerosis in the evolution of Alzheimer's disease: Can treatment reduce cognitive decline? J. Alzheimer's Dis. (JAD) 2010, 20, 893-901.
159. Terpstra, M.; Marjanska, M.; Henry, P. G.; Tkac, I.; Gruetter, R. Detection of an antioxidant profile in the human brain in vivo via double editing with MEGA-PRESS. Magn. Reson. Med. 2006, 56, 1192-1199.
160. Emir, U. E.; Raatz, S.; McPherson, S.; Hodges, J. S.; Torkelson, C.; Tawfik, P.; White, T.; Terpstra, M. Noninvasive quantification of ascorbate and glutathione concentration in the elderly human brain. NMR Biomed. 2011, 24, 888-894.